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This article reports a taxonomic classification of rare skeletal diseases based on
metabolic phenotypes. It was prepared by The Skeletal Rare Diseases Working
Group of the International Osteoporosis Foundation (IOF) and includes 116 OMIM
phenotypes with 86 affected genes.
Introduction
Rare skeletal metabolic diseases comprise a group of diseases commonly
associated with severe clinical consequences. In recent years, the description of
the clinical phenotypes and radiographic features of several genetic bone disorders
was paralleled by the discovery of key molecular pathways involved in the
regulation of bone and mineral metabolism. Including this information in the
description and classification of rare skeletal diseases may improve the recognition
and management of affected patients.
Methods
IOF recognized this need and formed a Skeletal Rare Diseases Working Group
(SRD-WG) of basic and clinical scientists who developed a taxonomy of rare
skeletal diseases based on their metabolic pathogenesis.
Results
This taxonomy of rare genetic metabolic bone disorders (RGMBDs) comprises 116
OMIM phenotypes, with 86 affected genes related to bone and mineral
homeostasis. The diseases were divided into four major groups, namely, disorders
due to altered osteoclast, osteoblast, or osteocyte activity; disorders due to altered
bone matrix proteins; disorders due to altered bone microenvironmental
regulators; and disorders due to deranged calciotropic hormonal activity.
Conclusions
This article provides the first comprehensive taxonomy of rare metabolic skeletal
diseases based on deranged metabolic activity. This classification will help in the
development of common and shared diagnostic and therapeutic pathways for these
patients and also in the creation of international registries of rare skeletal
diseases, the first step for the development of genetic tests based on next
generation sequencing and for performing large intervention trials to assess
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